Key result
Initial antihypertensive drug therapy approaches recommended by the ALLHAT trial remain debated, as senior editors present critiques questioning the study's conclusions.
Key points are not available for this paper at this time.
Design
Editorial
This editorial presents critiques of the ALLHAT trial results regarding initial antihypertensive drug therapy.
Results of the ALLHAT study have focused attention on the preferred approaches to the management of hypertension. Some of the conclusions of this trial have already been questioned. In this issue of The JCH, Marvin Moser, MD, and Michael A. Weber, MD, two of the senior editors, present their critiques of the ALLHAT results.
No takes yet. Share an insight, caveat, or question.
Marvin Moser (2003) studied this question. Initial antihypertensive drug therapy approaches recommended by the ALLHAT trial remain debated, as senior editors present critiques questioning the study's conclusions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: